drugset / Trial / NCT00002241

Safety and Effectiveness of an Anti-HIV Drug Combination Taken Twice Daily

NCT00002241

Phase 2 Unknown 80 enrolled Merck Sharp & Dohme LLC
Treatment

Summary

The purpose of this study is to see whether taking indinavir (IDV) plus ritonavir (RTV) plus stavudine (d4T) plus lamivudine (3TC) 2 times each day is safe and can lower the level of HIV in the blood.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject INDINAVIR ANHYDROUS Other / unclassified 800 mg
Subject Lamivudine Other / unclassified
Subject Ritonavir Other / unclassified 100 mg
Subject Stavudine Other / unclassified